Stocks / Stock overview

Chevron Corp (CVX)

Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.

$211.22Price
+0.21%Day change
$412.14BMarket cap

Aft $211.16 (-0.03%)

NYSE · Price as of · Delayed Quote

Stock Scorer
Scoring…
Analyst consensus
Buy$243.46
  • Analysts24
  • Implied upside+15.3%
  • Target range$202.00 to $272.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
January 29, 2027date estimated
  • EPS expected$5.69 +274%
  • A year ago$1.52
  • Revenue expected$65.16B +39%
  • Estimate range$4.99 to $7.00
Consensus of 18 analysts for the quarter ending December 31, 2026. Beat the estimate in all four of the last four quarters. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar

How Congress has done in CVX

Source: AIStockWire, scored from STOCK Act disclosures against daily price historyGenerated

Every purchase of CVX disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.

MeasureCVXSPY
Median 12-month return after purchase+22.1%+26.1%
Median difference vs SPY-0.4%—
Purchases that beat SPY11 of 22 (50%)—
Members who bought12—

Most frequent buyers: Marjorie Taylor Greene (4), Markwayne Mullin (3), Michael McCaul (3), Tommy Tuberville (3), Shelley Moore Capito (2).

These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 8 of the 22 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.

Congress trades in CVX

Source: STOCK Act disclosures filed with the House and SenateLatest disclosed

DateMemberActionAmount
2026-10-14Pete Sessions TXSale$15,001 - $50,000
2026-09-23Kevin Hern OKSale (Partial)$15,001 - $50,000
2026-09-02Maria Elvira Salazar FLPurchase$1,001 - $15,000
2026-07-02John Boozman ARPurchase$1,001 - $15,000
2026-06-26Michael McCaul TXSale (Full)$100,001 - $250,000
All congress trades

SEC filings

Source: SEC EDGARLatest filed

FormFiledDescription
144November 10, 2026View on EDGAR
10-QNovember 5, 202610-Q
4November 4, 2026PRIMARY DOCUMENT
144November 2, 2026View on EDGAR
8-KOctober 30, 20268-K
4October 21, 2026PRIMARY DOCUMENT
144October 19, 2026View on EDGAR
8-KOctober 6, 20268-K
All SEC filings

Frequently asked questions

When does CVX report earnings?

Chevron Corp (CVX) is scheduled to report quarterly results on January 29, 2027 (estimated). The 18-analyst consensus is $5.69 per share on revenue of $65.16B for the quarter ending December 31, 2026, against $1.52 and $46.87B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters. The date is an estimate from past reporting patterns and can move until the company confirms it.

What do analysts expect for CVX?

24 analysts cover Chevron Corp (CVX). The consensus rating is Buy. The average price target is $243.46, in a range of $202.00 to $272.00.

Are insiders buying or selling CVX?

We have no qualifying Form 4 insider purchases or sales on record for Chevron Corp (CVX). Sales are only tracked above a dollar threshold, so small routine trades may not appear.

Has Congress made money trading CVX?

12 members of Congress have disclosed buying CVX in the last 5 years, 22 purchases in total. Measured over the 12 months after each trade date, the median purchase returned +22.1% against +26.1% for SPY over the same windows, and 11 of the 22 (50%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.

Where can I see CVX SEC filings?

Recent filings are listed on this page, newest first. The latest is a 144 filed November 10, 2026.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.